#dreadds Tech News.
1 story in the last 7 days
The latest dreadds news, distilled by AI into sharp ~100-word summaries. ByteBrief tracks dreadds across dozens of tech sources and brings you only what matters, updated hourly. Tap any story for the full brief, or open the original source.
TechHacker Newsabout 2 hours ago
Chemogenetics enters human trials in ChinaChemogenetics, which engineers neurons to respond to designer drugs, has entered human clinical trials. Bryan Roth identified seven ongoing trials in China targeting pain, Parkinson's disease, and epilepsy, involving roughly 10 patients. The technique uses DREADDs and low-dose clozapine to precisely modulate brain activity.
Summaries by ByteBrief